Article Text

Use of matrix metalloproteinases 2 and 9 and white blood cell counts in monitoring the treatment and predicting the survival of horses with septic arthritis
  1. J. A. Kidd, BA, DVM, CertES(Orth), DiplECVS, MRCVS1,
  2. A. R. S. Barr, MA, VetMB, PhD, DVR, DEO, DiplECVS, CertSAO, MRCVS1 and
  3. J. F. Tarlton, BSc, PhD2
  1. 1 Division of Veterinary Clinical Studies
  2. 2 Matrix Biology Research Group, University of Bristol School of Veterinary Medicine, Langford House, Langford, Bristol BS40 5DU
  1. Dr Kidd's present address is The Valley Equine Hospital, Upper Lambourn Road, Lambourn, Berkshire RG17 8QG


Thirty-nine samples of synovial fluid were collected from the joints of 32 horses with suspected septic arthritis and 39 samples were collected from horses euthanased for non-orthopaedic conditions. The white blood cell counts (wbcc) were determined and the pro and active forms of matrix metalloproteinases (mmps) 2 and 9 were measured by gelatin zymography and image analysis in each sample. The initial measurements of the ratio of prommp9:prommp2 and wbcc were good prognostic indicators of the survival of the horses. There was no significant relationship between the interval between the injury and the horse being referred for treatment and either the wbcc or the levels of mmp2 and mmp9 initially, and no evidence that this interval significantly affected the chances of the horses surviving.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.